ethyl 7-oxo-1H,7H-imidazo[1,2-a]pyridine-3-carboxylate, 97%, 5g

(3-Fluoro-5-(hydroxymethyl)phenyl)boronic acid, 97%, 1g

HARPAGOSIDE, 97%, 100mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-methyl-1H-indol-3-yl)propanoic acid, 95%, 5g

Bicyclo[4.2.0]octa-1,3,5-trien-7-ylmethanol, 97.0%, 1g

1,1'-Dibenzyl-4,4'-bipyridinium Dichloride>98.0%(HPLC)1g

Methyl 2,4-Dihydroxybenzoate>98.0%(GC)(T)25g

N,N-Dimethyl-1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine, 95.0%, 25g

ethyl N-methyl-beta-alaninate, 95.0%, 500g

Hexadecyl Sulfide>97.0%(GC)25g

Diethyl Isopropylidenemalonate>98.0%(GC)5g

Vistusertib, 97%, 5mg

(E)-4-Methoxy-N-(2-(2-(pyridin-4-yl)vinyl)phenyl)benzenesulfonamide, 97.0%, 1mg